THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN™

CAPTION CONTEST


ENTER CONTEST
Your chance to win a $50!
November 2009 Cartoon

NEWS FEEDS


Loading...


WEB EXCLUSIVE          ARCHIVES


Wellness-Based Health Plans


Gene Reeder, RPh, PhD; Timothy S. Regan, BPharm, RPh, CPh

Diabetes Pipeline: New Strategies Emerging for Glycemic Control


By Wayne Kuznar

SUPPLEMENTS              ARCHIVES


Prescription Drug Benefit Cost and Plan Design Report: US Employers Begin to Adopt Value-Based Drug Plan Designs


Dana H. Felthouse, MBA; David E. Hickman, PharmD

Optimizing Outcomes in Asthma through a Pay-for-Quality-Performance Program


Allan T. Laskin, MD; Thomas James III, MD; Nicole G. Devita, RPh, MPH

ONLINE FIRST


Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care


Alyssa Pozniak, PhD; Lois Olinger, MA; Victoria Shier, MA
As the number of patients with diabetes increases, there is growing concern about the adequacy of reimbursement...FULL TEXT

COMMENTARIES


Scott Gottlieb, MD

How the US Government Rations Healthcare


Scott Gottlieb, MD
Everyone knows that private payers limit access to some health care, but government does it in far more byzantine and arbitrary ways... FULL TEXT

Doctors on Healthcare Reform


Betsy McCaughey
Medical professionals are being ignored or vilified more often than consulted in the current healthcare reform debate... FULL TEXT

EDITORIAL


Wellness and the Governing Dynamics of Healthcare Reform


Robert E. Henry
On October 29, 2009, the 2nd Annual Summit on Stakeholder Integration of AHDB was in progress in Washington, DC, to discuss the need to shift the focus to wellness-based care for chronic diseases... FULL TEXT

BUSINESS


Maureen Kubacki, PharmD, MBA

Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population


Maureen Kubacki, PharmD, MBA; Chureen Carter, PharmD, MS; Alan D.L. Herrera, PharmD; Jim Wang, PhD; Janice M. Lopez, PharmD; Catherine T. Piech, MBA
Insurance claims for patients with CKD average $5000 to $12,000 per patient per year...FULL TEXT
Stakeholder Perspective by Jeff Januska, PharmD

REGULATORY


Quality Improvement Initiatives: The Missed Opportunity for Health Plans


Sara Fernandez-Lopez, PhD; Barbara Lennert, RN, BSN, MAOM
Quality metrics have the potential to increase the value of the US healthcare system by reducing costs and increasing access to...FULL TEXT
Stakeholder Perspective by Jeffrey A. Bourret, MS, RPh, FASHP

GENERIC DRUG TRENDS


Increases in Drug Utilization and Patent Expirations: A Recipe for Growth of Generics' Market Share, despite Stalling on Biosimilars


Dalia Buffery, MA, ABD
The future of generics appears brighter than ever, with many brand-name medications pending patent expiration by 2011, accounting for about $34 billion in total sales in... FULL TEXT

INDUSTRY TRENDS


Management Tools for Molecular Diagnostic Testing: Financial and Clinical Implications


Douglas Moeller, MD
Now that gene tests, markers for tumor receptors, and a variety of other molecular probes have created an entirely new world of personalized medicine... FULL TEXT


E-mail address